Visakhapatnam

For our MNC Client.

Post: Junior Technical Officer – Granulation (5 positions)

About Authors:
Lohithasu Duppala^*1, Madhu priya Damuluri¹, Anil kumar vadda^2
1GITAM Institute of Pharmacy, GITAM University, Pharmaceutics, visakhapatnam, Andhra Pradesh, India-530045.
²AVANTHI Institute of pharmaceutical sciences, pharmacology, visakhapatnam, Andhra Pradesh, India-530045.
^*lohithasu@gmail.com, anilkumar.vadda@gmail.com

ABSTRACT:
COX-2 (Cyclooxygenase-2) is a selective inhibitor of non-steroidal anti-inflammatory drug (NSAID). Cyclooxygenase -2, an enzyme responsible for inflammation and pain. Celecoxib, Rofecoxib, valdecoxib, Parecoxib are class of COX-2 inhibiting drugs. COX-2  inhibitors have been revealed to reduce the occurrence of cancers and pre-cancerous growths. Celecoxib, cox-2 inhibitor isused to prevention of polyp formation in Familial Adenomatous Polyposis (FAP). COX-2 inhibitors like celecoxib, Rofecoxib, valdecoxib, Parecoxibare currently being studied in  cancer treatment and other targets. This review highlights the COX-2 inhibitors with special emphasis on their role in various kinds of cancer prevention and other targeted therapy. COX-2 inhibitors in cancer chemotherapy and neurological diseases like Parkinson and Alzheimer’s diseases still continues to attract researches on the development of COX-2 inhibitors.

Formula HR Consulting for MNC client

Post: Junior Technical Officer- Tablet Coating ( 5 positions)

Company based in Tokyo, Japan is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Company corporate human health care (hhc) mission is to give first thought to patients and their families, and to increase the benefits that health care provides. Pharmatechnology and Manufacturing Pvt. Ltd, a subsidiary of Co.

Eisai Co., Ltd. based in Tokyo, Japan is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

Eisai Co., Ltd. based in Tokyo, Japan is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

Eisai Inc. is a U.S.

Walk in interview for the post of PROJECT FELLOW (One) in a research project  entitled  "Bio-Analytical   Investigations  of Anti-Cancer drugs' sponsored by the University Grants Commission (U.G.C), New Delhi.

Post: Project Fellow - 1